Zhengye Biotechnology Holding Limited (ZYBT)
NASDAQ: ZYBT · Real-Time Price · USD
8.36
+0.80 (10.58%)
At close: Aug 13, 2025, 4:00 PM
8.40
+0.04 (0.48%)
After-hours: Aug 13, 2025, 4:10 PM EDT

ZYBT Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21
396----
Enterprise Value
362----
Debt / Equity Ratio
0.250.250.270.180.09
Debt / EBITDA Ratio
2.132.131.300.770.44
Debt / FCF Ratio
3.153.152.20-2.35
Asset Turnover
0.380.380.420.54-
Inventory Turnover
1.631.631.662.27-
Quick Ratio
0.800.800.770.950.86
Current Ratio
1.311.311.261.411.31
Return on Equity (ROE)
3.89%3.89%10.78%16.50%-
Return on Assets (ROA)
2.07%2.07%5.51%8.53%-
Return on Capital (ROIC)
2.37%2.37%6.61%10.68%-
Return on Capital Employed (ROCE)
4.60%4.60%12.90%17.90%16.40%
Payout Ratio
-141.66%125.42%45.84%28.36%
Updated Nov 15, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q